首页> 外国专利> Procedure for replication of influenza viruses in cell culture and influenza viruses obtainable by the process

Procedure for replication of influenza viruses in cell culture and influenza viruses obtainable by the process

机译:在细胞培养中复制流感病毒的程序以及可通过该方法获得的流感病毒

摘要

A process for making a vaccine for administration to humans or animals comprising: a) replication of influenza viruses in cell culture, in which cells that can be infected by influenza viruses are cultured in cell culture in suspension in serum free medium, the cells are infected with influenza viruses and after infection are cultured at a temperature in the range of 32º C to 34º C for virus replication, wherein a protease is added to the cultured cells before, during or after infection with influenza virus; b) collecting and isolating the influenza viruses replicated 2 to 10 days after infection, in which the cells or cell residues are separated from the culture medium; c) the formulation of influenza viruses to give the vaccine replicates, wherein: the infectivity of the replicated virus is destroyed by chemical and / or physical or viruses present in the vaccine as live attenuated viruses.
机译:一种制备用于人或动物的疫苗的方法,包括:a)在细胞培养物中复制流感病毒,其中将可被流感病毒感染的细胞在无血清培养基中悬浮于细胞培养物中进行培养,感染细胞用流感病毒感染并感染后的病毒在32ºC至34ºC的温度范围内培养以复制病毒,其中在感染流感病毒之前,之中或之后将蛋白酶添加到培养的细胞中; b)收集并分离在感染后2至10天复制的流感病毒,其中从培养基中分离出细胞或细胞残基; c)配制流感病毒以提供疫苗复制品,其中:复制的病毒的传染性被作为减毒活病毒存在于疫苗中的化学和/或物理或病毒破坏。

著录项

  • 公开/公告号ES2435726T3

    专利类型

  • 公开/公告日2013-12-23

    原文格式PDF

  • 申请/专利权人 NOVARTIS VACCINES AND DIAGNOSTICS GMBH;

    申请/专利号ES20090011476T

  • 发明设计人 VORLOP JUERGEN;GROENER ALBRECHT;

    申请日1997-04-01

  • 分类号C12N5/06;C12N7/00;A61K38/48;A61K39/145;C12N5/02;C12N7/01;C12N7/02;G01N33/569;

  • 国家 ES

  • 入库时间 2022-08-21 15:55:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号